Abstract:As a result of the discovery that flavonoids are directly or indirectly connected to health, flavonoid metabolism and its fascinating molecules that are natural products in plants, have attracted the attention of both the industry and researchers involved in plant science, nutrition, bio/chemistry, chemical bioengineering, pharmacy, medicine, etc. Subsequently, in the past few years, flavonoids became a top story in the pharmaceutical industry, which is continually seeking novel ways to produce safe and efficient drugs. Microbial cell cultures can act as workhorse bio-factories by offering their metabolic machinery for the purpose of optimizing the conditions and increasing the productivity of a selective flavonoid. Furthermore, metabolic engineering methodology is used to reinforce what nature does best by correcting the inadequacies and dead-ends of a metabolic pathway. Combinatorial biosynthesis techniques led to the discovery of novel ways of producing natural and even unnatural plant flavonoids, while, in addition, metabolic engineering provided the industry with the opportunity to invest in synthetic biology in order to overcome the currently existing restricted diversification and productivity issues in synthetic chemistry protocols. In this review, is presented an update on the rationalized approaches to the production of natural or unnatural flavonoids through biotechnology, analyzing the significance of combinatorial biosynthesis of agricultural/pharmaceutical compounds produced in heterologous organisms. Also mentioned are strategies and achievements that have so far thrived in the area of synthetic biology, with an emphasis on metabolic engineering targeting the cellular optimization of microorganisms and plants that produce flavonoids, while stressing the advances in flux dynamic control and optimization. Finally, the involvement of the rapidly increasing numbers of assembled genomes that contribute to the gene- or pathway-mining in order to identify the gene(s) responsible for producing species-specific secondary metabolites is also considered herein.

Metabolic engineering for plant natural products biosynthesis: new procedures, concrete achievements and remaining limits

Engineering fungal secondary metabolism: a roadmap to novel compounds.

Emerging trends in plant natural products biosynthesis: a chemical perspective

Creating Novel Metabolic Pathways by Protein Engineering for Bioproduction

Metabolic engineering of plant medicines

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Combinatorial biosynthesis for the engineering of novel fungal natural products

Advances in the development and application of microbial consortia for metabolic engineering

Metabolic Engineering in Plants: Advancing Crop Productivity and Sustainability through Precision Pathway Manipulation

Synthetic metabolism: metabolic engineering meets enzyme design

When plants produce not enough or at all: metabolic engineering of flavonoids in microbial hosts

Metabolic Engineering: Methodologies and Applications.

Synthetic Biology of Natural Products Engineering: Recent Advances Across the Discover-Design-Build-Test-Learn Cycle

Metabolic engineering is a promising way to generate highly effective producers of bioactive substances

Recent advances in the heterologous expression of microbial natural product biosynthetic pathways

Debottlenecking cytochrome P450-dependent metabolic pathways for the biosynthesis of commercial natural products

Metabolic engineering of microorganisms: general strategies and drug production

Cutting-edge plant natural product pathway elucidation

Metabolic Engineering of Streptomyces to Enhance the Synthesis of Valuable Natural Products